Adline Ghazi is an Endocrinology/Metabolic physician. OpenAlex indexes 54 publications with 1,556 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pennsylvania Ave NW
Suite 5-404
Washington, DC 200373201
Telephone
202-741-3333Registry record last updated 22 Mar 2011.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Radius Health, Inc.Program year20251 payment
- Amgen Inc.Program year20251 payment
- Dexcom, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
59%GLP-1 receptor agonist25.3%Ozempic52%Mounjaro24%Trulicity21%Rybelsus3%Part D<11 patientsInsulin Analog13%Lantus Solostar24%Tresiba Flextouch U-10022%Basaglar Kwikpen U-10012%Tresiba Flextouch U-20010%Humalog Kwikpen U-1009%Novolog Flexpen7%Toujeo Solostar6%Toujeo Max Solostar4%Insulin Lispro Kwikpen U-1004%Humalog4%Part D<11 patients+ 5 more classes in this area
Cardiovascular
21%Statin12.3%Atorvastatin Calcium57%Rosuvastatin Calcium34%Pravastatin Sodium8%Part D<11 patientsCalcium channel blocker2.5%Amlodipine Besylate80%Nifedipine Er20%Part D<11 patients+ 5 more classes in this area
Hormonal (systemic)
16.5%l-Thyroxine12.4%Levothyroxine Sodium92%Synthroid8%Part D<11 patientsThyroid Hormone Synthesis Inhibitor2.9%Methimazole100%Part D≥28 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”